Skip to content

Journal of Education, Health and Sport

ISSN 2391-8306

20 papers in the library · 4 citations · publishing 2019-2026

Papers

Sort Most recent Most cited

Ketamine for Treatment-Resistant Depression in Adolescents: Hope or Risk?

Journal of Education, Health and Sport September 24, 2026 Anna Kamosińska, Julia Pająk, Olga Sławatyniec et al.

Treatment-resistant depression (TRD) in adolescents remains a major clinical challenge because of the limited efficacy of conventional antidepressants and the high risk of suicidal behavior. Ketamine has emerged as a rapidly acting antidepressant with a unique glutamatergic mechanism, promoting neuroplasticity and reducing neuroinflammation. Clinical studies demonstrate significant symptom...

Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder

Journal of Education, Health and Sport July 16, 2026 Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek et al.

Background. Post-Traumatic Stress Disorder (PTSD) is an important public health challenge typically treated with trauma-focused psychotherapy and Selective Serotonin Reuptake Inhibitors (SSRIs). However, high rates of residual symptoms associated with these standard treatments have led to a renewed interest in psychedelic-assisted therapies. Aim. This review attempts to examine emerging...

Ketamine and Esketamine in Depression: Current Evidence on Mechanisms, Efficacy, Safety and Clinical Use – A Review

Journal of Education, Health and Sport June 22, 2026 Urszula Szuleta, Wiktoria Zawada, Krystian Kaczmarek et al.

Introduction and purpose. Major depressive disorder is a serious clinical problem. Current treatments are often unsuccessful, and many patients do not achieve full remission. In a reanalysis of the STAR*D study, the cumulative remission rate after up to four treatment steps was about 41%, which highlights the limitations of currently available antidepressant strategies[1]. In recent years,...

Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects — A Narrative Review

Journal of Education, Health and Sport May 7, 2026 Kinga Zachar, M. Sito, Filip Jurkowski et al.

Introduction and purpose: Depressive disorders, particularly major depressive disorder (MDD) and treatment-resistant depression (TRD), remain major causes of disability worldwide. Conventional treatments are limited by delayed onset, incomplete response, relapse, and adverse effects. This review summarizes current evidence on the efficacy, safety, and durability of psilocybin-assisted therapy...

Esketamine in Treatment-Resistant Depression and Suicidal Ideation: A Systematic Review

Journal of Education, Health and Sport November 29, 2025 Natalia Dudziak, Zuzanna Drozd, Bartosz Niemiec et al.

Background. Major depressive disorder affects 20% of the global population, with treatment-resistant depression in 10-30% of cases. Patients with acute suicidal ideation need immediate intervention, yet conventional antidepressants require weeks to work. Esketamine offers rapid symptom reduction through NMDA receptor antagonism. Aim. To systematically review current evidence on efficacy and...

Role of ketamine in treatment-resistant depression

Journal of Education, Health and Sport April 5, 2025 Joanna Dmochowska, Marcin Ciechański, Joanna Cieszkowska et al. 1 citation

Introduction: Depression, affecting 350 million people globally, is a leading cause of disability. Common symptoms include low mood, sadness, guilt, anxiety, and suicidalthoughts. Current treatments, mostly monoamine-based antidepressants, have limitations such as delayed effects and low efficacy, with over 60% of patients not achieving lasting remission. Ketamine, an NMDA antagonist, has shown...

Risks of using psilocybin in treatment of treatment-resistant depression

Journal of Education, Health and Sport March 7, 2025 Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek et al.

Introduction As depression rates continue to rise globally, the need for more effective and innovative treatments has become increasingly urgent, highlighting the potential impact of psilocybin as a promising therapeutic option. However, to ensure its safe and effective integration into clinical practice, it is essential to establish robust safety parameters for its administration. This paper...

DOI: 10.12775/JEHS.2025.79.58319 (opens in new tab) Full text (opens in new tab) Treatment resistant depression Safety Psychedelic assisted therapy Adverse effects +1

Ketamine in the Treatment of Depression

Journal of Education, Health and Sport February 17, 2025 Urszula Kaczmarska, Michał Jakub Cioch, Julia Nowak et al.

Introduction Depression is one of the most common mental illnesses. Over the course of a lifetime, several percent of the adult population suffers from depression. There are many treatments for depression like pharmacotherapy and psychotherapy. In this article, we wanted to focus on the effectiveness of ketamine in treating depression. Aim of study The study aimed to summarize the available...

Applications of MDMA in Modern Medicine - A Literature Review

Journal of Education, Health and Sport January 14, 2025 Wiktoria Podlasiewicz, Paweł Siudziński, Mateusz Łyko et al.

MDMA or 3,4- methylenedioxymethamphetamine is a psychoactive substance, exhibiting mild hallucinogenic properties, that became widely known as a recreational party drug. However, its ability in helping individuals access deeply rooted emotions has prompted significant interest in its potential applications within clinical practice. MDMA’s mechanism of action involves increasing the release of...

DOI: 10.12775/jehs.2025.77.56620 (opens in new tab) MDMA Traditional medicine Pharmacology

Recreational ketamine use and its impact on health

Journal of Education, Health and Sport September 24, 2024 Jakub Perłowski, Marek Miśkiewicz, Jakub Ptak et al. 2 citations

Ketamine, also known as 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone, is a dissociative anesthetic that has gained popularity as a recreational substance among young people, especially in nightclubs and at parties. It acts as a noncompetitive NMDA receptor antagonist, inducing a dissociative state that manifests as catalepsy, unconsciousness and amnesia. Recreational use of ketamine and the...

DOI: 10.12775/jehs.2024.68.55185 (opens in new tab) Ketamine Recreation Environmental health Physical therapy

Psilocybin as a new way for depression treatment

Journal of Education, Health and Sport May 15, 2024 Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak et al.

Introduction: Mental disorders are common and still growing problem around the globe. Significantly decreasing quality of life, they are often source of true suffering for patients and their families leading to further health issues or even dramatic outcomes resulting in death. As public awareness rises, more and more people understand risks and tend to look for help as fast as possible....

DOI: 10.12775/jehs.2024.68.50168 (opens in new tab) Psilocybin Depression economics Hallucinogen Psychotherapist +1

Mindfulness and Movement: Scientifically Exploring the Health Impacts of Yoga

Journal of Education, Health and Sport April 11, 2024 Martyna Hys, Jakub Kuśmierski, Izabela Janik et al.

Introduction: Yoga combines asanas (postures), pranayamas (breathing exercises), and dhyanas (meditation) to improve physical and mental well-being. It's recognized for its substantial health benefits, safety, and cost-effectiveness, leading to calls for its broader integration into healthcare for its therapeutic and preventative potential. This study aims to explore yoga's multifaceted health...

DOI: 10.12775/jehs.2024.64.014 (opens in new tab) Full text (opens in new tab) Yoga Health benefits Health status Physical fitness

Stress and primary headaches – Mindfulness-Based Stress Reduction (MBSR) as a novel avenue for treatment

Journal of Education, Health and Sport February 24, 2024 Julia Szymonik, Sebastian Szopa

Introduction: In today's fast-paced life, an increasing number of people are experiencing chronic stress, which negatively impacts our mental and physical health, leading to troublesome conditions such as primary headaches. Faced with this challenge, more individuals are turning their attention to mindfulness techniques as an effective tool for stress management. In light of this, mindfulness,...

Psychedelics as a treatment for patients with post-traumatic stress disorder (PTSD)

Journal of Education, Health and Sport February 22, 2024 Krzysztof Marcinkowski, Agata Mazur, Magdalena Madera et al.

Introduction and purpose: Post-traumatic stress disorder is a psychiatric condition following an extreme event that causes a near death of an involved individual. Since conventional treatments using selective serotonin reuptake inhibitors do not consistently yield therapeutic success, alternative substances are being explored as potential solutions. This study aims to compile information...

Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge

Journal of Education, Health and Sport December 30, 2023 Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś

Introduction and purpose: Nowadays, when mental disorders are considered by the World Health Organisation as a global burden, the potential usage of psychedelic drugs as supportive therapy is gaining more attention worldwide. The aim of this paper is to summarize the usefulness of psilocybin - representative of psychedelics - in psychiatric venues. In this review we describe its properties,...

DOI: 10.12775/jehs.2023.50.01.005 (opens in new tab) Psilocybin Depression economics Adverse effect Hallucinogen +2

use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review

Journal of Education, Health and Sport August 15, 2023 Karol Womperski, Rafał Bogacz, Magdalena Gaik et al. 1 citation

Introduction: Post-traumatic stress disorder (PTSD) is a common health issue of complex etiology significantly deteriorating functioning in everyday life. It may develop as a result of exposure to traumatic events like traffic accidents, war experience, sexual abuse and domestic violence. Current methods of treatment consist of trauma-oriented psychotherapy supported by selective serotonin...

The use of psilocybin in the treatment of psychiatric disorders – review

Journal of Education, Health and Sport August 15, 2023 Justyna Woźniak, Rafał Bogacz, Magdalena Gaik et al.

Introduction: The word “psychedelic” derives from the Greek language and can be loosely translated as “mind manifesting” which is to convey that these substances allow the mind to unleash its hidden potential. Psilocybin is considered to be a “classic psychedelic” and is most commonly found in the form of so-called “magic mushrooms”. Due to its unique properties psilocybin has been used during...

Psilocybin's Emerging Role in Combating Depressive Disorder

Journal of Education, Health and Sport August 8, 2023 Anna Jaremek, Joanna Kępa, Norbert Kandefer et al.

In this review paper, we delve into the potential applicability of psilocybin - a naturally synthesized psychedelic substance found within select species of fungi, as a prospective avenue for depression treatment. Depression, a widespread psychological malady affecting countless individuals across the globe, often proves stubborn against existing treatment modalities, necessitating exploration...

Major depression disorder - etiology and treatment

Journal of Education, Health and Sport June 7, 2023 Paulina Czuchryta, Rafał Babiak, Karolina Bajak et al.

Introduction and purpose: The problem of major depression disorder (MDD) affects more and more people. In a few years, it may become the most common disease after cardiovascular diseases and cancer. MDD are manifested by a depressed mood, decreased energy, loss of interest and the ability to enjoy life, as well as a number of other additional symptoms. Untreated MDD can lead to disability. This...

Mindfulness and its influence on quality of life and immune response in women with breast cancer

Journal of Education, Health and Sport October 5, 2019 Katarzyna Kosz, Martyna Zielińska, Natalia Zarankiewicz et al. preprint

Mindfulness therapy is a psychological process, which main purpose is to concentrate attention on internal and external stimuli in the present moment. Practising mindfulness is correlated with well-being, greater energy and enthusiasm as well as the ability to cope with stressful situations. Breast cancer accounts for 22% of all malignant tumors in women. It is characterized by the highest...

DOI: 10.5281/zenodo.3380716 (opens in new tab) Full text (opens in new tab) Breast cancer Mindfulness-based stress reduction Quality of life